Molmed: Japanese takeover bid, ok from Fininvest, rally on the stock market
The price offered by Agc recognizes a premium of 110,3% on Monday's closing price - The Berlusconi family will collect around 55 million
MolMed: losses halved, revenues +53%, stock runs
The net result is in the red by 2,4 million, a loss more than halved compared to the -4,9 million recorded at the end of the January-September period last year
Molmed takes off on the Stock Exchange: EU green light for new therapy
Rain of purchases on the stock after the European Commission has decided to grant the conditional placing on the market for the cell therapy Zalmoxis.
Borsa: Molmed flies after the green light for therapies
The biotech company stands out in Piazza Affari, recording increases of more than 5%, with exchanges much higher than the average - The AIFA authorization to produce and market gene therapies is driving the prices.
MolMed: new drug against asbestos cancer
The company listed on the Italian Stock Exchange has developed a therapeutic agent that can increase the survival of patients with pleural mesothelioma, a tumor typically associated with exposure to asbestos fibres.
Molmed, 5 million capital increase under way
The Milan-based biotech company kicks off its 5 million euro capital increase this morning - Many shareholders, among which Fininvest stands out, have already expressed their willingness to fully subscribe the stake in…
MolMed deposits treatment associated with stem cell transplantation and goes public
The biotech company, the only one listed with Italian capital on the Milan Stock Exchange, is about to place its experimental cell-gene therapy on the market ahead of schedule - The news, in the wake of the excellent results of 2013 and a few days after the…
Stock exchange, MolMed flies on clinical study expansion in the USA
The share of the Milanese biotechnology company advances decisively in Piazza Affari, with increases of around 8% in the morning - MolMed shares are given wings by the announcement of the expansion in the United States of a clinical study for the treatment of…